Last 12 months
Inside the activity.
0 purchase rows · 91 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 12 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 16 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2023 Filed Dec 15, 2023 01:13 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 994 | $62.90 | $62,522.60 |
DisclosureSEC source: 0001209191-23-058707 · doc4.xml · nonDerivative · entry 7 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,554,690 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.6436 to $63.3256 inclusive. F2 · ownership.direct: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 01:13 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 4,155 | $62.42 | $259,355.10 |
DisclosureSEC source: 0001209191-23-058707 · doc4.xml · nonDerivative · entry 6 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 856,824 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.5297 to $62.5175 inclusive. F3 · ownership.nature: These shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Opportunity I"). Atlas Venture Associates Opportunity I, L.P. ("Associates I") is the general partner of Atlas Opportunity I. Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. Each of Associates I and Associates I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Opportunity I, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 01:13 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 6,234 | $62.42 | $389,126.28 |
DisclosureSEC source: 0001209191-23-058707 · doc4.xml · nonDerivative · entry 5 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,555,684 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.5297 to $62.5175 inclusive. F2 · ownership.direct: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 01:13 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 422 | $60.99 | $25,737.78 |
DisclosureSEC source: 0001209191-23-058707 · doc4.xml · nonDerivative · entry 4 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 860,979 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.50 inclusive. F3 · ownership.nature: These shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Opportunity I"). Atlas Venture Associates Opportunity I, L.P. ("Associates I") is the general partner of Atlas Opportunity I. Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. Each of Associates I and Associates I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Opportunity I, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 01:13 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 632 | $60.99 | $38,545.68 |
DisclosureSEC source: 0001209191-23-058707 · doc4.xml · nonDerivative · entry 3 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,561,918 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.50 inclusive. F2 · ownership.direct: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 01:13 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 20,823 | $59.87 | $1,246,673.01 |
DisclosureSEC source: 0001209191-23-058707 · doc4.xml · nonDerivative · entry 2 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 861,401 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.497 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), (11) and (12). F3 · ownership.nature: These shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Opportunity I"). Atlas Venture Associates Opportunity I, L.P. ("Associates I") is the general partner of Atlas Opportunity I. Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. Each of Associates I and Associates I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Opportunity I, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| December 12, 2023 Filed Dec 15, 2023 01:13 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 31,235 | $59.87 | $1,870,039.45 |
DisclosureSEC source: 0001209191-23-058707 · doc4.xml · nonDerivative · entry 1 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Atlas Venture Opportunity Fund I, L.P. · CIK 0001759241 · 10% owner Atlas Venture Associates Opportunity I, L.P. · CIK 0001780065 · 10% owner Atlas Venture Associates Opportunity I, LLC · CIK 0001780066 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,562,550 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.50 to $60.497 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), (11) and (12). F2 · ownership.direct: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 22:40 UTC |
Ashiya MonaDirector
|
SaleCommon Stock | 3,600 | $60.16 | $216,576.00 |
DisclosureSEC source: 0000947871-23-001147 · ownership.xml · nonDerivative · entry 3 Ashiya Mona · CIK 0001794070 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 295,605 F3 · ownership.nature: These securities are held of record by OrbiMed Genesis Master Fund, L.P. ("Genesis"). OrbiMed Genesis GP LLC ("Genesis GP") is the general partner of Genesis and OrbiMed Advisors is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by Genesis and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by Genesis. F4 · ownership.nature: Each of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, and Genesis GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of her or its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, or Genesis GP is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 22:40 UTC |
Ashiya MonaDirector
|
SaleCommon Stock | 9,300 | $60.16 | $559,488.00 |
DisclosureSEC source: 0000947871-23-001147 · ownership.xml · nonDerivative · entry 2 Ashiya Mona · CIK 0001794070 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 764,307 F2 · ownership.nature: These securities are held of record by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VI. F4 · ownership.nature: Each of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, and Genesis GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of her or its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, or Genesis GP is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 22:40 UTC |
Ashiya MonaDirector
|
SaleCommon Stock | 14,400 | $60.16 | $866,304.00 |
DisclosureSEC source: 0000947871-23-001147 · ownership.xml · nonDerivative · entry 1 Ashiya Mona · CIK 0001794070 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 1,182,425 F1 · ownership.nature: These securities are held of record by OrbiMed Private Investments VIII, LP ("OPI VIII"). OrbiMed Capital GP VIII LLC ("GP VIII") is the general partner of OPI VIII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VIII. The Reporting Person is an employee of OrbiMed Advisors. By virtue of such relationships, GP VIII and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VIII and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VIII. F4 · ownership.nature: Each of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, and Genesis GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of her or its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, or Genesis GP is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $13.50 | $0.00 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · derivative · entry 10 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2032-12-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,427 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · derivative · entry 9 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,216 Underlying: Common Stock · 5,427 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,084 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · derivative · entry 8 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,024 Underlying: Common Stock · 21,084 shares Expires 2030-11-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares underlying this option vest in 16 equal quarterly installments following November 27, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
SaleCommon Stock | 4,057 | $66.10 | $268,151.07 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · nonDerivative · entry 7 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.3684, inclusive. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
SaleCommon Stock | 16,263 | $65.26 | $1,061,341.27 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · nonDerivative · entry 6 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,057 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.995, inclusive. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
SaleCommon Stock | 1,091 | $63.73 | $69,532.05 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · nonDerivative · entry 5 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,320 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.51 to $63.883, inclusive. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
SaleCommon Stock | 12,100 | $59.44 | $719,214.32 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · nonDerivative · entry 4 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,411 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.6974, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
Exercise / conversionCommon Stock | 7,000 | $13.50 | $94,500.00 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · nonDerivative · entry 3 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
Exercise / conversionCommon Stock | 5,427 | $9.86 | $53,510.22 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · nonDerivative · entry 2 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
White William RichardDirector
|
Exercise / conversionCommon Stock | 21,084 | $2.65 | $55,872.60 |
DisclosureSEC source: 0000950170-23-070396 · ownership.xml · nonDerivative · entry 1 White William Richard · CIK 0001778739 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-23-070394 · ownership.xml · derivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,253 Underlying: Common Stock · 2,500 shares Expires 2030-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F3 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following January 1, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
SaleCommon Stock | 2,500 | $65.22 | $163,061.50 |
DisclosureSEC source: 0000950170-23-070394 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.05 to $65.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionCommon Stock | 2,500 | $2.65 | $6,625.00 |
DisclosureSEC source: 0000950170-23-070394 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 755 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · derivative · entry 7 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 752 Underlying: Common Stock · 755 shares Expires 2029-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F5 · derivative.exercise_date: The shares underlying this option vest in 16 equal quarterly installments following May 1, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 526 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · derivative · entry 6 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 526 shares Expires 2029-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F4 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
SaleCommon Stock | 100 | $57.06 | $5,706.00 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 5 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,500 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
SaleCommon Stock | 1,293 | $56.55 | $73,114.75 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 4 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,600 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.05 to $57.04, inclusive. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
SaleCommon Stock | 1,148 | $55.29 | $63,478.32 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,893 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.93 to $55.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionCommon Stock | 755 | $1.01 | $762.55 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 21:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionCommon Stock | 526 | $1.01 | $531.26 |
DisclosureSEC source: 0000950170-23-068812 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2023. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC |
Khara RahulGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · derivative · entry 4 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,804 Underlying: Common Stock · 10,000 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F4 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC |
Khara RahulGeneral Counsel
|
SaleCommon Stock | 9,900 | $51.75 | $512,299.26 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.27 to $52.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC |
Khara RahulGeneral Counsel
|
SaleCommon Stock | 100 | $50.34 | $5,034.00 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,900 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $50.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:15 UTC |
Khara RahulGeneral Counsel
|
Exercise / conversionCommon Stock | 10,000 | $14.69 | $146,900.00 |
DisclosureSEC source: 0000950170-23-066117 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
| November 15, 2023 Filed Nov 15, 2023 22:00 UTC |
Khara RahulGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,900 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · derivative · entry 4 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,804 Underlying: Common Stock · 4,900 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F4 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 22:00 UTC |
Khara RahulGeneral Counsel
|
SaleCommon Stock | 787 | $51.05 | $40,174.54 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · nonDerivative · entry 3 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.01 to $51.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 22:00 UTC |
Khara RahulGeneral Counsel
|
SaleCommon Stock | 4,113 | $50.53 | $207,837.29 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 787 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.01 to $51.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 14, 2023 Filed Nov 15, 2023 22:00 UTC |
Khara RahulGeneral Counsel
|
Exercise / conversionCommon Stock | 4,900 | $14.69 | $71,981.00 |
DisclosureSEC source: 0000950170-23-064228 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 23:22 UTC |
Khara RahulGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100 | $0.00 Strike: $14.69 | $0.00 |
DisclosureSEC source: 0000950170-23-060503 · ownership.xml · derivative · entry 3 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,704 Underlying: Common Stock · 100 shares Expires 2032-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. F2 · derivative.exercise_date: 25% of the shares underlying this option vested on December 20, 2022, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 23:22 UTC |
Khara RahulGeneral Counsel
|
SaleCommon Stock | 100 | $50.00 | $5,000.00 |
DisclosureSEC source: 0000950170-23-060503 · ownership.xml · nonDerivative · entry 2 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
| November 03, 2023 Filed Nov 7, 2023 23:22 UTC |
Khara RahulGeneral Counsel
|
Exercise / conversionCommon Stock | 100 | $14.69 | $1,469.00 |
DisclosureSEC source: 0000950170-23-060503 · ownership.xml · nonDerivative · entry 1 Khara Rahul · CIK 0001951850 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 22, 2023. Read SEC document |
| September 16, 2023 Filed Sep 18, 2023 20:59 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 2,115 | $53.22 | $112,560.30 |
DisclosureSEC source: 0001209191-23-049778 · doc4.xml · nonDerivative · entry 3 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593,785 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.05 to $53.365 inclusive. F2 · ownership.direct: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 20:59 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 260,894 | $53.16 | $13,869,125.04 |
DisclosureSEC source: 0001209191-23-049778 · doc4.xml · nonDerivative · entry 2 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,595,900 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.60 inclusive. F2 · ownership.direct: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:59 UTC |
Atlas Venture Fund X, L.P.10% owner
ATLAS VENTURE ASSOCIATES X, L.P.10% owner
Atlas Venture Associates X, LLC10% owner
|
SaleCommon Stock | 94,440 | $53.05 | $5,010,042.00 |
DisclosureSEC source: 0001209191-23-049778 · doc4.xml · nonDerivative · entry 1 Atlas Venture Fund X, L.P. · CIK 0001628098 · 10% owner ATLAS VENTURE ASSOCIATES X, L.P. · CIK 0001742766 · 10% owner Atlas Venture Associates X, LLC · CIK 0001742765 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,856,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.42 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4). F2 · ownership.direct: These shares are held directly by Atlas Venture Fund X, L.P. ("Atlas X"). Atlas Venture Associates X, L.P. ("Associates X") is the general partner of Atlas X. Atlas Venture Associates X, LLC ("Associates X LLC") is the general partner of Associates X. Each of Associates X and Associates X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas X, except to the extent of its pecuniary interest therein, if any. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 20:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $9.86 | $0.00 |
DisclosureSEC source: 0000950170-23-047933 · ownership.xml · derivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,745 Underlying: Common Stock · 2,500 shares Expires 2031-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 20:15 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionCommon Stock | 2,500 | $9.86 | $24,650.00 |
DisclosureSEC source: 0000950170-23-047933 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:16 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-23-046397 · ownership.xml · derivative · entry 3 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,753 Underlying: Common Stock · 1,000 shares Expires 2030-10-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. F2 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments following October 7, 2020, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:16 UTC |
Bryce JoanneChief Financial Officer
|
SaleCommon Stock | 1,000 | $52.99 | $52,990.00 |
DisclosureSEC source: 0000950170-23-046397 · ownership.xml · nonDerivative · entry 2 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,260 F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:16 UTC |
Bryce JoanneChief Financial Officer
|
Exercise / conversionCommon Stock | 1,000 | $2.65 | $2,650.00 |
DisclosureSEC source: 0000950170-23-046397 · ownership.xml · nonDerivative · entry 1 Bryce Joanne · CIK 0001951845 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 20:06 UTC |
Savage William JacobChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0000950170-23-043894 · ownership.xml · derivative · entry 2 Savage William Jacob · CIK 0001951852 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,326 Underlying: Common Stock · 3,000 shares Expires 2030-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.